Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of disorders in which
chronic inflammation of the skeletal muscle, leading to muscle weakness, is a common …

Update on autoantibodies and related biomarkers in autoimmun... : Current Opinion in
Rheumatology Update on autoantibodies and related biomarkers in autoimmune inflammatory …

Abstract Purpose of Review Systemic sclerosis (SSc) and myositis are two different entities
that may coexist as an overlap syndrome. Immunological biomarkers such as anti-PM/Scl or …

Background In patients with idiopathic inflammatory myopathies (IIM), autoantibodies are
associated with specific clinical phenotypes suggesting a pathogenic role of adaptive …

Myositis-specific autoantibodies (MSAs) have become pivotal biomarkers for idiopathic
inflammatory myopathies and have revolutionized understanding of the heterogeneous …

Autoimmune rheumatic disease (AIRD) is a collective term, which comprises a group of
multisystem inflammatory autoimmune diseases, including connective tissue diseases …

Objectives To determine prevalence and clinical associations of anti-Four-and-a-half-LIM-
domain 1 (FHL1) autoantibodies in patients with idiopathic inflammatory myopathies (IIM) …

Myositis-specific autoantibodies (MSAs) are hallmarks of idiopathic inflammatory
myopathies (IIMs) and have become increasing valuable in disease diagnosis, phenotyping …

Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of disorders in which
chronic inflammation of the skeletal muscle is a common feature. Myositis-specific and …

Idiopathic inflammatory myopathies (IIMs), or myositis, are a heterogeneous group of
autoimmune disorders characterized by chronic inflammation of the muscle with a variety in …